Sun Pharma
Search results
Dr. Reddy’s Laboratories, a leading multinational pharmaceutical company based in India and overseas, committed to providing affordable and innovative medicines for healthier lives.
Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. [2] . Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas.
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) is a global pharmaceutical company headquartered in Hyderabad, India. Established in 1984, we are committed...
Dr. Reddy’s Laboratories commenced its generics business in India in 1986 and is today a trusted name in the healthcare industry consistently serving the needs of millions of patients with high quality, affordable and innovative medicines across therapy areas.
49 minutes ago · Welcome to the Dr. Reddy's Laboratories Stock Liveblog, your ultimate source for real-time updates and analysis of one of the most prominent stocks in the market. Stay on top of the game with our comprehensive coverage, featuring the latest details on Dr. Reddy's Laboratories stock, including: Last traded price 6479.35, Market capitalization: 108087.39, Volume: 541, Price-to-earnings ratio 19.38, Earnings per share 334.37. Get a holistic view of Dr. Reddy's Laboratories with our expert ...
Jun 27, 2024 · The acquisition being made by Dr. Reddy’s Laboratories SA is on an upfront cash consideration of GBP 458 million and additional performance-based contingent cash payments of up to GBP 42 million ...
Dr. Reddy’s Laboratories. 2,617 followers. 11mo. Just finished "Leading with Innovation" by Anil Gupta, and Haiyan Wang! Check it out: https://lnkd.in/dPk5yk-B #innovationmanagement. Arpit...
Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services and...
2 days ago · Acquisition of Nicotinell will give Dr Reddy’s access to key global customers, markets, talent Analysts are jittery as the acquired portfolio is a slow-growing business Dr Reddy’s Laboratories ...
We accelerate access to affordable and innovative medicines because Good Health Can’t Wait. | Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) is a...
